Rothschild Investment LLC’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-160
| Closed | -$1.04K | – | 3198 |
|
2025
Q1 | $1.04K | Buy |
160
+40
| +33% | +$259 | ﹤0.01% | 2320 |
|
2024
Q4 | $881 | Buy |
120
+40
| +50% | +$294 | ﹤0.01% | 2285 |
|
2024
Q3 | $599 | Buy |
80
+20
| +33% | +$150 | ﹤0.01% | 2418 |
|
2024
Q2 | $534 | Buy |
60
+50
| +500% | +$445 | ﹤0.01% | 1970 |
|
2024
Q1 | $101 | Buy |
+10
| New | +$101 | ﹤0.01% | 2209 |
|
2023
Q3 | – | Sell |
-24,850
| Closed | -$610K | – | 497 |
|
2023
Q2 | $610K | Sell |
24,850
-3,400
| -12% | -$83.5K | 0.05% | 276 |
|
2023
Q1 | $657K | Sell |
28,250
-300
| -1% | -$6.98K | 0.06% | 266 |
|
2022
Q4 | $723K | Sell |
28,550
-5,100
| -15% | -$129K | 0.07% | 245 |
|
2022
Q3 | $649K | Sell |
33,650
-1,500
| -4% | -$28.9K | 0.06% | 251 |
|
2022
Q2 | $895K | Sell |
35,150
-2,100
| -6% | -$53.5K | 0.08% | 225 |
|
2022
Q1 | $958K | Sell |
37,250
-1,300
| -3% | -$33.4K | 0.08% | 234 |
|
2021
Q4 | $1.61M | Hold |
38,550
| – | – | 0.13% | 161 |
|
2021
Q3 | $1.68M | Sell |
38,550
-2,000
| -5% | -$87.1K | 0.14% | 153 |
|
2021
Q2 | $1.92M | Sell |
40,550
-900
| -2% | -$42.5K | 0.15% | 141 |
|
2021
Q1 | $2.13M | Buy |
41,450
+18,550
| +81% | +$951K | 0.18% | 123 |
|
2020
Q4 | $613K | Buy |
22,900
+10,150
| +80% | +$272K | 0.06% | 257 |
|
2020
Q3 | $438K | Buy |
+12,750
| New | +$438K | 0.05% | 278 |
|